German Vaccine Maker Says Waivers for Vaccines Not Right Approach

The granting of intellectual property waivers is not the right way to increase output of COVID-19 vaccines, the founder of German vaccine maker BioNTech said on Wednesday, advocating instead the award of production licenses. Such waivers are among the options …

from News – Insurance Journal https://ift.tt/3sXbKoj